Elizabeth G Gibson

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Escherichia Coli

Urinary Tract Infection

Top Venues

ACS infectious diseases

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, Karen Mattern, Keir C Neuman, Pan F Chan, Neil Osheroff
Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS infectious diseases 10 (4) (2024)
Alexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, Karen Mattern, Keir C Neuman, Pan F Chan, Neil Osheroff
Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS infectious diseases 10 (4) (2024)
Alexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, Karen Mattern, Keir C Neuman, Pan F Chan, Neil Osheroff
Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS infectious diseases 10 (4) (2024)
Alexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, Karen Mattern, Keir C Neuman, Pan F Chan, Neil Osheroff
Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS infectious diseases 10 (4) (2024)
Alexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, Karen Mattern, Keir C Neuman, Pan F Chan, Neil Osheroff
Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS infectious diseases 10 (4) (2024)
Alexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, Karen Mattern, Keir C Neuman, Pan F Chan, Neil Osheroff
Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS infectious diseases 10 (4) (2024)
Alexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, Karen Mattern, Keir C Neuman, Pan F Chan, Neil Osheroff
Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS infectious diseases 10 (4) (2024)
Elizabeth G Gibson, Olivia Campagne, Nicholas S Selvo, Amar Gajjar, Clinton F Stewart
Population pharmacokinetic analysis of crizotinib in children with progressive/recurrent high-grade and diffuse intrinsic pontine gliomas. Cancer chemotherapy and pharmacology 88 (6) (2021)
Elizabeth G Gibson, Benjamin D Bax, Pan F Chan, Neil Osheroff
Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase. ACS infectious diseases 5 (4) (2019)
Elizabeth G Gibson, Alexandria A Oviatt, Monica Cacho, Keir C Neuman, Pan F Chan, Neil Osheroff
Bimodal Actions of a Naphthyridone/Aminopiperidine-Based Antibacterial That Targets Gyrase and Topoisomerase IV. Biochemistry 58 (44) (2019)
Elizabeth G Gibson, Tim R Blower, Monica Cacho, Ben Bax, James M Berger, Neil Osheroff
Mechanism of Action of Mycobacterium tuberculosis Gyrase Inhibitors: A Novel Class of Gyrase Poisons. ACS infectious diseases 4 (8) (2018)